Stericycle's ExpertSolutions unit acquires a European marketing and recalls business
Saying that “Our pharma clients have global brands, and there’s been a demand for global recalls management to protect those brands,” Mike Rozembajgier, VP of recalls for Stericycle (Indianapolis), expanded on the company’s recent acquisition of Eclipse Marketing, a Wokingham, UK marketing services company. Within Stericycle, which has a global business of medical waste handling and disposal, the ExpertSolutions unit handle reverse logistics for pharma and other consumer-goods companies. Eclipse will be added to ExpertSolutions, which provides related product management services such as field audits and mystery shoppers (who conduct in-field market research in retail).
Recalls can be a critical part of pharma marketing and distribution—and with significant financial risk to a manufacturer if product that needs to be retrieved remains in the supply chain. (A parallel business, product returns, involves the retrieval and sometimes redistribution of overstock at, for example, local pharmacies.) Eclipse’s website notes that the company has significant business in customer-relationship management, including a multi-channel call center, and that it does business both in the UK and on the Continent. Rozembajgier says that generally speaking, product recalls need to be handled within the borders of the region in which they occur. An added responsibility is to provide safe and secure disposal of the recalled products.
Rozembajgier says that business has been up substantially for ExpertSolutions in the first half of this year (which is bad news for pharma manufacturers, who are trying to maintain a better level of control over final product quality). Product recalls are increasingly a data-driven process, with data exchange between the manufacturer, the recall manager and the retailer to manage reimbursement and to verify product disposition. “From recall notification to product handling, storage and destruction, we can assist companies in managing through their global recall crisis in a seamless fashion with access to all the critical data elements,” he concludes.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.